USA: Bernie Sanders holds pharmaceutical labs accountable
US Senator Bernie Sanders intends to send Monday a letter to the Catalyst Pharmaceuticals laboratory asking him to justify his decision to charge $ 375,000 a year (327,500 euros) at the list price a treatment that was freely accessible for years. Firdapse is used against Lambert-Eaton Myasthenic Syndrome, a rare neuromuscular disease that affects approximately […]
Continue Reading